Telehealth Intervention to improve Heart Failure care after hospital discharge
- Conditions
- Heart FailureC14.280
- Registration Number
- RBR-10vpf9bm
- Lead Sponsor
- Faculdade de Medicina da Universidade Federal de Minas Gerais
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Age >18 years; diagnosis of heart failure (HF) with left ventricular ejection fraction (LVEF) =50%, from Echocardiogram, Cardiac Magnetic Resonance Imaging or Myocardial Scintigraphy; hospitalization for HF with discharge scheduled for the next few days or recent hospitalization for HF with discharge less than 2 weeks ago; at least one medication of the conventional treatment (betablockers, ACEI/ARB/ARNI, MRA) not started or two medications among those with a prescribed dosage less than or equal to 50% of the target dose; and who agree to participate and sign the Informed Consent Form
CKD (chronic kidney disease) stage V; Previous heart transplant or active patient on the heart transplant list; Previous use of Ventricular assist device; Cardiac amyloidosis; Pregnant or planning to become pregnant; Estimated life expectancy of less than 6 months related to non-cardiac comorbidities according to the investigator's judgment; Defined as for palliative support; Current participation in another study to investigate devices or drugs, or have participated in another study in the last 30 days; Patient or caregiver who lives in the same household without access to Smartphone; Patient without cognitive conditions to make own decisions; Illiterate patients (do not know how to read and/or write) without a responsible caregiver; patient who for some reason will not be available to complete the procedures (eg interviews) established in the study
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method